Clinical Trials Directory

Trials / Conditions / Travelers' Diarrhea

Travelers' Diarrhea

12 registered clinical trials studyying Travelers' Diarrhea — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingG.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies
NCT06556940
Lumen Bioscience, Inc.EARLY_Phase 1
RecruitingEtiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia
NCT06363890
Lumen Bioscience, Inc.—
CompletedClinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model
NCT05933525
Immuron Ltd.Phase 2
TerminatedA Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.
NCT02920242
SandozPhase 3
CompletedTrial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
NCT02498301
Henry M. Jackson Foundation for the Advancement of Military MedicineN/A
TerminatedProbiotics and the Prevention of Traveler's Diarrhea
NCT01005849
Lallemand SASPhase 4
CompletedTravelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study
NCT00993681
Intercell USA, Inc.Phase 3
WithdrawnSingle Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea
NCT00875875
The University of Texas Health Science Center, HoustonPhase 4
CompletedDose-Finding Study of CS19 Expressing ETEC Challenge Strains
NCT00564863
Johns Hopkins Bloomberg School of Public HealthPhase 1
CompletedSafety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD
NCT00524004
Johns Hopkins Bloomberg School of Public HealthPhase 2
CompletedDose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli ETEC Challenge Strains That Express C
NCT00564577
Johns Hopkins Bloomberg School of Public HealthPhase 1
CompletedRifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea
NCT00292344
The University of Texas Health Science Center, HoustonPhase 4